Clinical Trial Details
EORTC-20856
Back to Clinical Trials Database
Maintenance of remission with recombinant alpha-2 Interferon (Roferon-A) in patients with stages III and IV low grade Non-Hodgkin's lymphoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Oct-1986 Date Step1 close: 11-Mar-1997 Date Step2 close: 11-Mar-1997 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 300 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
